NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
$62.60
arrow_upward
+0.71%(+0.44) 1D
Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
$62.58
High
$63.27
Low
$61.86
Mkt. cap
172.47B
Avg. vol.
24.05K
Volume
22.19K
52-wk high
$75.26
52-wk low
$49.90
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
Open
$62.58
High
$63.27
Low
$61.86
Mkt. cap
172.47B
Avg. vol.
24.05K
Volume
22.19K
52-wk high
$75.26
52-wk low
$49.90
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
Dairy Business Middle East & Africa
·
1 day ago
Novonesis strengthens dairy innovation with facility expansion
AD HOC NEWS
·
1 day ago
Novonesis completes MicroBioGen acquisition: Novonesis stock trades EUR 55.72
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR